Zhikang Robotics Acquired by Dahhu Health Industry to Advance into Rehabilitation Robotics

On January 13, 2026, the signing ceremony for the strategic cooperation between Dahu Health Industry Co., Ltd. and Shanghai Zhikangjia Robot Co., Ltd. was held in Shanghai. Dahu Shares intends to acquire a total of 40% equity interest in ZHIKANG ROBOT from natural person Xu Peiqi and Shanghai Qijuli Partner Robot. Upon completion, the listed company and its subsidiary, Dongfang Huakang, will jointly increase capital in ZHIKANG ROBOT. After the acquisition and capital increase transactions are completed, the listed company will directly hold a 42% equity interest in ZHIKANG ROBOT, while its subsidiary, Dongfang Huakang, will directly hold a 10% equity interest. Consequently, ZHIKANG ROBOT and Shanghai Zhikangjia Robot Co., Ltd. will become controlling subsidiaries of the listed company.

Following this round of financing, ZHIKANG ROBOT will deepen multi-business synergy and resource integration under the industrial empowerment of Dahu Shares and the professional support of Dongfang Huakang, while continuing to focus on core technology iteration and product scenario expansion. In the future, the company will further cultivate the rehabilitation and nursing sector, leveraging technological innovation to address industry pain points, bringing intelligent rehabilitation equipment into more households, and safeguarding healthy living for the elderly.

ZHIKANG ROBOT, incubated by the Shanghai Industrial Technology Research Institute for Robotics, is a Class A project under the Tongxiang City Entrepreneurial Leading Talent Program, a “People’s Choice Star” of the World Artificial Intelligence Conference’s “Future Tech 100,” and a benchmark enterprise for intelligent robotics in Shanghai. As a pioneer and leader in the field of home-based upper-limb rehabilitation robots, it leverages deep medical-engineering collaboration with the Rehabilitation Research Institute of Shanghai Jiao Tong University School of Medicine to focus on the research, development, and industrialization of cutting-edge technologies, including rehabilitation robotics, brain-computer interfaces, and wearable exoskeletons.

To date, the company has successfully developed three upper-limb rehabilitation robot products: the Medical Edition, the Institutional Professional Edition, and the Personal Miaoshou Edition. The entire product line is strictly manufactured in compliance with the ISO 13485 quality management system standards.

The Medical Edition is a full-cycle, multi-scenario intelligent upper-limb rehabilitation robot that has obtained Class II medical device registration certification. It offers functions such as assessment, training, and reporting, and features a portable design weighing only 7 kg. In addition to providing more than 20 training exercises and over 10 gamified training scenarios, it supports multiple training modes, including passive, assistive, active, resistive, mirror therapy, and brain-computer interface (BCI).

Backpack Rehabilitation Therapist – Miaoshou Edition has been included in the “Shanghai Community Rental Service Catalog for Rehabilitation Assistive Devices.” The adaptive force interaction technology, independently developed by ZHIKANG ROBOT, provides patients with more personalized and efficient upper limb rehabilitation training. Combined with cognitive intervention functions, it is suitable for individuals at different stages of rehabilitation as well as active seniors.

Dahu Shares (Stock Code: 600257) was listed on the Shanghai Stock Exchange on June 12, 2000, and was officially renamed “Dahu Health Industry Co., Ltd.” on October 28, 2025. The company’s traditional core business focuses on health products centered around freshwater aquaculture, covering ecological fisheries, prepared dishes, and baijiu (Chinese white liquor). In recent years, the company has firmly implemented a strategic transformation toward the big health industry, forming a dual-core drive of “health products” and “healthcare services.” Its strategic core is to build a complete industrial chain from healthy food to professional medical services, catering to health needs across the entire life cycle. In 2020, the company successfully entered the rehabilitation and nursing care sector by acquiring Dongfang Huakang Medical Management Co., Ltd., laying a solid foundation for its healthcare services segment. This joint investment in ZHIKANG ROBOT by Dahu Shares and its controlling subsidiary, Dongfang Huakang, marks a key step in deepening the company’s strategic layout in “healthcare services.”

Dongfang Huakang Medical Management Co., Ltd. is the core platform and holding subsidiary of Dahua Shares in the health and medical services sector. As a specialized medical management group integrating rehabilitation, nursing, medical care, and teaching, the company focuses primarily on hospital investment and management. Currently, Dongfang Huakang operates seven medical institutions in the Yangtze River Delta region, including Shanghai Jincheng Nursing Hospital and Wuxi Guoji Rehabilitation Hospital, with over 3,000 available rehabilitation and nursing beds, making it one of the leading private rehabilitation and nursing medical groups in the region by scale. With rehabilitation medicine as its specialty, the company has established medical consortia with several renowned Grade A tertiary hospitals, committed to building a high-quality and efficient rehabilitation and nursing service system. As a co-implementer of this merger and capital increase, Dongfang Huakang will deeply integrate its extensive clinical scenarios and operational expertise with the cutting-edge technology of ZHIKANG ROBOT, jointly promoting the implementation and innovation of intelligent rehabilitation solutions.